Globus Medical (GMED) announced that Keith Pfeil, Executive Vice President, COO and CFO, has been appointed President and CEO effective July 18, 2025. Daniel Scavilla has resigned as President and CEO effective July 18, 2025, in order to pursue another opportunity. Additionally, Kyle Kline, Senior Vice President of Finance, has been appointed Senior Vice President and CFO.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GMED:
- Globus Medical price target lowered to $68 from $75 at Morgan Stanley
- Barclays bullish on Globus Medical, sees share upside to $103
- Globus Medical Approves Key Proposals at Annual Meeting
- Needham medtech & diagnostics analyst holds analyst/industry conference call
- AMD, Block upgraded: Wall Street’s top analyst calls